查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2016044

呼吸系統診斷市場報告：按產品和服務類型、測試類型、疾病、最終用戶和地區分類，2026-2034 年

Respiratory Diagnostics Market Report by Product and Service Type, Test Type, Disease, End-User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2025年全球呼吸系統診斷市場規模達91億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到159億美元，2026年至2034年的複合年成長率為6.17%。推動市場成長的因素包括呼吸系統疾病盛行率上升、醫療保健成本增加、人口老化以及對早期準確診斷的需求不斷成長，以改善患者預後並有效管理慢性疾病。

呼吸系統診斷是指對肺功能及相關過程進行臨床評估。這包括多種機械、影像和分子診斷測試，用於檢測氣喘、慢性阻塞性肺病（COPD）、肺癌、支氣管炎和肺纖維化。這些檢查包括肺量計檢查、血氧飽和度測量、經皮二氧化碳監測、鼻吸氣壓力（SNIP）測量、胸部X光檢查和電腦斷層掃描（CT）。在某些情況下，可能需要進行睡眠研究，以診斷和評估是否有睡眠呼吸中止症或夜間低通氣。

呼吸系統疾病盛行率的上升是市場成長的主要驅動力之一。吸菸率和飲酒量的增加，加上久坐的生活方式和壓力大的日常生活，導致慢性阻塞性肺病（COPD）和肺癌等嚴重呼吸系統疾病的發生率上升。此外，呼吸系統診斷檢測領域的各種技術創新，包括在COPD的診斷和門診管理中應用物聯網（IoT）和人工智慧（AI），也對市場成長產生了積極影響。各私立醫院和醫療中心對呼吸系統診斷設備的需求不斷成長，以及政府和非政府組織（NGO）為確保人人享有優質醫療保健所做的努力，也推動了呼吸系統診斷市場的發展。其他促進市場成長的因素包括研發投入的增加、老年人口的成長、快速的都市化和工業化進程，以及日益嚴重的全球污染。

本報告解答的主要問題：

  • 迄今為止，全球市場的發展趨勢是什麼？您認為未來幾年這些趨勢將如何演變？
  • 全球呼吸系統診斷市場的促進因素、限制因素和近期機會是什麼？
  • 各個促進因素、限制因素和機會如何影響全球市場？
  • 主要區域市場有哪些？
  • 哪個國家是最具吸引力的市場？
  • 依產品/服務類型分類的市場區隔如何？
  • 市場上最具吸引力的產品/服務類型是什麼？
  • 按測試類型分類的市場區隔如何？
  • 市面上哪種類型的檢測最具吸引力？
  • 按疾病分類的市場區隔如何？
  • 目前市面上最受關注的疾病是什麼？
  • 依最終用戶分類的市場區隔如何？
  • 市場上最具吸引力的終端用戶群是哪一類？
  • 該市場的競爭結構是怎麼樣的？
  • 全球市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球呼吸系統診斷市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場區隔：依產品/服務類型
  • 市場區隔：按測試類型
  • 市場區隔：依疾病分類
  • 市場區隔：依最終用戶分類
  • 市場區隔：按地區
  • 市場預測

第6章 市場區隔：依產品/服務類型分類

  • 設備和服務
  • 檢測方法和試劑
  • 服務軟體

第7章 市場區隔：依測試類型分類

  • 機械測試
  • 阻塞型睡眠呼吸中止症）的診斷測試
  • 影像檢查
  • 常規診斷測試
  • 分子診斷測試
  • 其他

第8章 市場區隔：依疾病分類

  • 結核
  • 氣喘
  • 慢性阻塞性肺病（COPD）
  • 肺癌
  • 其他

第9章 市場區隔：依最終用戶分類

  • 醫院
  • 診所
  • 實驗室/臨床檢查室
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Philips Healthcare
    • Abbott Laboratories
    • Biomerieux
    • Becton Dickinson
    • Thermo Fisher Scientific Inc.
    • Alere Inc.
    • Seegene Inc.
    • 3M
    • Bio-Rad Laboratories Inc.
    • SDI Diagnostics
    • COSMED
Product Code: SR112026A1620

The global respiratory diagnostics market size reached USD 9.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 15.9 Billion by 2034, exhibiting a growth rate (CAGR) of 6.17% during 2026-2034. The growing prevalence of respiratory diseases, rising healthcare expenditure, increasing aging population, and heightened demand for early and accurate diagnosis to improve patient outcomes and manage chronic conditions effectively are some of the factors impelling the market growth.

Respiratory diagnostics refer to the clinical assessment of lung functioning and related processes. It includes several mechanical, imaging and molecular diagnostic tests for detecting asthma, chronic obstructive pulmonary disease (COPD), lung cancer, bronchitis, and pulmonary fibrosis. It uses procedures, such as spirometry, oximetry, transcutaneous CO2 monitoring, sniff nasal inspiratory pressure (SNIP), chest X-ray and computed tomography (CT) scan. In some instances, sleep studies are also conducted to diagnose and assess the presence of sleep apnea and nocturnal hypoventilation.

The growing prevalence of respiratory diseases is one of the key factors driving the growth of the market. The increasing number of smokers and consumption of alcohol, coupled with sedentary lifestyle habits and stressful routines, have resulted in rising incidences of COPD and other severe respiratory conditions, such as lung cancer. Furthermore, various technological innovations in respiratory diagnostic testing, including the utilization of Internet of Things (IoT) and Artificial Intelligence (AI) for the diagnosis of COPD and outpatient management, are creating a positive impact on the market growth. Also, an increase in the demand for respiratory diagnostics devices in various privately-owned hospitals and healthcare centers and efforts by both government and non-governmental organizations (NGO) to make quality healthcare facilities accessible to all are driving the market for respiratory diagnostics. Other factors contributing to the market growth include enhanced research and development (R&D), rising geriatric population, rapid urbanization and increasing industrial establishments, and growing pollution levels across the globe.

Key Market Segmentation:

The publisher provides an analysis of the key respiratory diagnostics market trends in each segment, along with forecasts at the global and regional levels for 2026-2034. Our report has categorized the market based on product and service type, test type, disease, and end-user.

Breakup by Product and Service Type:

  • Instruments and Services
  • Assays and Reagents
  • Services and Software

Breakup by Test Type:

  • Mechanical Tests
  • Obstructive Sleep Apnoea (OSA) Diagnostic Tests
  • Imaging Tests
  • Traditional Diagnostic Tests
  • Molecular Diagnostic Tests
  • Others

Breakup by Disease:

  • Tuberculosis
  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Lung Cancer
  • Others

Breakup by End-User:

  • Hospitals
  • Clinics
  • Reference and Clinical Laboratories
  • Others

Breakup by Region:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

The report has also analyzed the competitive landscape of the market with some of the key players being Philips Healthcare, Abbott Laboratories, Biomerieux, Becton Dickinson, Thermo Fisher Scientific Inc., Alere Inc., Seegene Inc., 3M, Bio-Rad Laboratories, SDI Diagnostics and COSMED.

Key Questions Answered in This Report:

  • How has the global market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and respiratory diagnostics market recent opportunities in the global market?
  • What is the impact of each driver, restraint, and opportunity on the global market?
  • What are the key regional markets?
  • Which countries represent the most attractive market?
  • What is the breakup of the market based on the product and service type?
  • Which is the most attractive product and service type in the market?
  • What is the breakup of the market based on the test type?
  • Which is the most attractive test type in the market?
  • What is the breakup of the market based on the disease?
  • Which is the most attractive disease in the market?
  • What is the breakup of the market based on the end-user?
  • Which is the most attractive end-user in the market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Respiratory Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product and Service Type
  • 5.5 Market Breakup by Test Type
  • 5.6 Market Breakup by Disease
  • 5.7 Market Breakup by End-User
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast

6 Market Breakup by Product and Service Type

  • 6.1 Instruments and Services
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Assays and Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services and Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Mechanical Tests
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Obstructive Sleep Apnoea (OSA) Diagnostic Tests
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Imaging Tests
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Traditional Diagnostic Tests
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Molecular Diagnostic Tests
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Disease

  • 8.1 Tuberculosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Asthma
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Chronic Obstructive Pulmonary Disease (COPD)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Lung Cancer
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Reference and Clinical Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Middle East and Africa
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Latin America
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Philips Healthcare
    • 14.3.2 Abbott Laboratories
    • 14.3.3 Biomerieux
    • 14.3.4 Becton Dickinson
    • 14.3.5 Thermo Fisher Scientific Inc.
    • 14.3.6 Alere Inc.
    • 14.3.7 Seegene Inc.
    • 14.3.8 3M
    • 14.3.9 Bio-Rad Laboratories Inc.
    • 14.3.10 SDI Diagnostics
    • 14.3.11 COSMED

List of Figures

  • Figure 1: Global: Respiratory Diagnostics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 2: Global: Respiratory Diagnostics Market: Breakup by Product and Service Type (in %), 2025
  • Figure 3: Global: Respiratory Diagnostics Market: Breakup by Test Type (in %), 2025
  • Figure 4: Global: Respiratory Diagnostics Market: Breakup by Disease (in %), 2025
  • Figure 5: Global: Respiratory Diagnostics Market: Breakup by End User (in %), 2025
  • Figure 6: Global: Respiratory Diagnostics Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Respiratory Diagnostics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 8: Global: Respiratory Diagnostics Industry: SWOT Analysis
  • Figure 9: Global: Respiratory Diagnostics Industry: Value Chain Analysis
  • Figure 10: Global: Respiratory Diagnostics Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Respiratory Diagnostics (Instruments and Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Respiratory Diagnostics (Instruments and Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Respiratory Diagnostics (Assays and Reagents) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Respiratory Diagnostics (Assays and Reagents) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Respiratory Diagnostics (Services and Software) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Respiratory Diagnostics (Services and Software) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Respiratory Diagnostics (Mechanical Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Respiratory Diagnostics (Mechanical Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Respiratory Diagnostics (Obstructive Sleep Apnoea Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Respiratory Diagnostics (Imaging Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Respiratory Diagnostics (Imaging Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Respiratory Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Respiratory Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Respiratory Diagnostics (Other Test Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Respiratory Diagnostics (Other Test Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Respiratory Diagnostics (Tuberculosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Respiratory Diagnostics (Tuberculosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Respiratory Diagnostics (Asthma) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Respiratory Diagnostics (Asthma) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Respiratory Diagnostics (Chronic Obstructive Pulmonary Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Respiratory Diagnostics (Lung Cancer) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Respiratory Diagnostics (Lung Cancer) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Respiratory Diagnostics (Other Disease Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Respiratory Diagnostics (Other Disease Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Respiratory Diagnostics (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Respiratory Diagnostics (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Respiratory Diagnostics (Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Respiratory Diagnostics (Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Respiratory Diagnostics (Reference and Clinical Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Global: Respiratory Diagnostics (Other End-Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Global: Respiratory Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: North America: Respiratory Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: North America: Respiratory Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Europe: Respiratory Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Europe: Respiratory Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Asia Pacific: Respiratory Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Asia Pacific: Respiratory Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Middle East and Africa: Respiratory Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Middle East and Africa: Respiratory Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Latin America: Respiratory Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Latin America: Respiratory Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034

List of Tables

  • Table 1: Global: Respiratory Diagnostics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Respiratory Diagnostics Market Forecast: Breakup by Product and Service Type (in Million USD), 2026-2034
  • Table 3: Global: Respiratory Diagnostics Market Forecast: Breakup by Test Type (in Million USD), 2026-2034
  • Table 4: Global: Respiratory Diagnostics Market Forecast: Breakup by Disease (in Million USD), 2026-2034
  • Table 5: Global: Respiratory Diagnostics Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 6: Global: Respiratory Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Respiratory Diagnostics Market Structure
  • Table 8: Global: Respiratory Diagnostics Market: Key Players